States are now trying to import Canadian drug prices rather than Canadian prescription drugs. Model legislation drafted by the National Academy for State Health Policy (NASHP) has inspired a slew of bills including one recently proposed in Pennsylvania, calling on the state to draw up an annual list of the 250 most expensive drugs, and then tie maximum reimbursement rates for those drugs to pricing in Canada’s four largest provinces. Drawing upon ICER’s price increase reports, NASHP is also suggesting legislation that penalizes drugmakers that increase prices without evidence of additional clinical benefit. Read more here and here.
You are here: / / States Push for Adoption of Canadian Drug Prices